Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists

Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists

US Patent 11034688 · Granted Jun 15, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Arylosulfonamides for the treatment of CNS diseases2015
Arylosulfonamides for the treatment of CNS diseases2015